TVTX
NASDAQ
$55.47
Travere Therapeutics Inc (TVTX)
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $58.36 (+5.21%)
Market Cap
$5.24B
Revenue 5Y CAGR
+22.05%
Free Cash Flow Yield
0.74%
Beta (5Y)
1.28
Price Chart
Valuation
Market Cap$5.24B
Forward P/E77.52
P/S9.84
P/B53.75
Profitability
Total Revenue (TTM)$536M
Gross Profit (TTM)$300M
EBITDA$16M
Profit Margin-29.2%
Operating Margin-29%
EPS-$0.23
Financial Health
Free Cash Flow Yield0.74%
Growth & Risk
EPS 5Y CAGR-44.12%
Revenue 5Y CAGR+22.05%
Beta (5Y)1.28
Sharpe Ratio1.99